Pharis Mohideen - 20 Nov 2025 Form 4 Insider Report for DBV Technologies S.A. (DBVT)

Reporting relationship: Chief Medical Officer
Issuer ticker: DBVT
Reported as of: 20 Nov 2025
Net transaction value: -$23,207
SEC form: 4
Accepted by SEC: 25 Nov 2025, 16:15:05 UTC
Prior SEC filing: 31 Jul 2025
Next SEC filing: 02 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Virginie Boucinha, Attorney-in-Fact

Key filing fact

Pharis Mohideen filed Form 4 for DBV Technologies S.A. (DBVT) on 25 Nov 2025.

Key facts

This page summarizes Pharis Mohideen's Form 4 filing for DBV Technologies S.A. (DBVT).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Nov 2025, 16:15.

Change

Previous filing in this sequence was filed on 31 Jul 2025.
Current net transaction value: -$23,207.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001760395 Primary reporting owner

Mohideen Pharis

Relationship: Chief Medical Officer
Address: C/O DBV TECHNOLOGIES S.A., 107, AVENUE DE LA REPUBLIQUE, CHATILLON, FRANCE
Signature: /s/ Virginie Boucinha, Attorney-in-Fact
Signature date: 25 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DBVT transaction

Ordinary Shares

Sale

Transaction value: $18,708
Shares: -6,496
Change %: -5.9%
Price: $2.88
Shares after: 103,153
Date: 20 Nov 2025
Ownership: Direct
Footnotes: F1, F2, F3

DBVT transaction

Ordinary Shares

Sale

Transaction value: $4,498
Shares: -1,624
Change %: -1.6%
Price: $2.77
Shares after: 101,529
Date: 21 Nov 2025
Ownership: Direct
Footnotes: F1, F2, F4

DBVT transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +44,000
Change %: +43%
Price: $0.000000
Shares after: 145,529
Date: 21 Nov 2025
Ownership: Direct
Footnotes: F1, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DBVT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +253,000
Change %
Price: $0.000000
Shares after: 253,000
Date: 21 Nov 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 253,000
Exercise price: $2.90
Footnotes: F4, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.

Footnote F2

Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.

Footnote F3

This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15268 to EURO 1.00 as of November 20, 2025.

Footnote F4

This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.

Footnote F5

Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

Footnote F6

The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.